SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-05-004506
Filing Date
2005-03-09
Accepted
2005-03-09 16:35:46
Documents
4
Period of Report
2005-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f06695e8vk.htm 8-K 13327
2 EXHIBIT 99.1 f06695exv99w1.htm EX-99.1 50288
3 EXHIBIT 99.2 f06695exv99w2.htm EX-99.2 6861
4 GRAPHIC f06695f0669500.gif GRAPHIC 2735
  Complete submission text file 0000950134-05-004506.txt   75165
Mailing Address
Business Address 1240 ELKO DR SUNNYVALE CA 94089
ADEZA BIOMEDICAL CORP (Filer) CIK: 0000902482 (see all company filings)

IRS No.: 770054952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20703 | Film No.: 05669719
SIC: 2835 In Vitro & In Vivo Diagnostic Substances